DPx Holdings B.V. Donates to Hospitals and Organizations - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

DPx Holdings B.V. Donates to Hospitals and Organizations


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 6

DPx Holdings B.V., a provider of custom manufacturing, technologies, and development services to the pharmaceutical, biopharmaceutical, and agrochemical industries, donated $110,000 to more than 20 different hospitals and organizations across the globe.

DPx Holdings B.V. was formed earlier this year as a result of a merger between Patheon and DSM Pharmaceutical Products. The company is comprised of three core business units, Patheon Pharma Services, DSM Fine Chemicals, and Banner Life Sciences.

The $5,000 donations were made on behalf of each site to thank employees for their efforts to help improve the lives of patients. Each site selected a local hospital or organization that makes a direct impact on patients in the community.

Source: DPx Holdings B.V.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
6%
All of the above.
42%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here